Author

S. Chevrier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Assay:proteomics· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:batch correction / integration· 1

Frequent Co-Authors

A. Jacobs· 4 shared B. Bodenmiller· 4 shared S. Sivapatham· 3 shared A. Rudiger· 2 shared C. Cervia· 2 shared E. Bächli· 2 shared J. Nilsson· 2 shared L. C. Huber· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

A. Jacobs

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Standardization of suspension and imaging mass cytometry readouts for clinical decision making

R. Casanova, S. Xu, S. Sivapatham, A. Jacobs, S. Engler, Tumor Profiler Consortium, M. P. Levesque, R. Dummer, B. Bodenmiller, S. Chevrier

This study standardizes suspension and imaging mass cytometry measurements to improve clinical reproducibility and provide oncologists with tumor biology insights.

bioRxiv · Mar 19, 2023 · PreprintCancer Biology

Effects of tumor mutation burden on the antigen presentation pathway

E. M. Garcia-Rivera, J. Park, A. Desai, R. Boidot, S. Chevrier, C. Truntzer, F. Ghiringhelli, M. Borad, A. S. Mansfield

The paper examines how tumor mutation burden affects antigen presentation pathway genes and finds that APG mutations are linked to improved progression-free survival with PD-1 inhibitors.

bioRxiv · Apr 14, 2021 · PreprintImmunology

Single-Cell Proteomics Defines the Cellular Heterogeneity of Localized Prostate Cancer

L. De Vargas Roditi, A. Jacobs, J. H. Rueschoff, P. Bankheac, S. Chevrier, H. Jackson, T. Hermanns, C. Fankhauser, C. Poyet, F. Chun, A. Tschaebunin, B. Bodenmiller, P. Wild

This study uses single-cell proteomics to identify cellular heterogeneity in localized prostate cancer and discovers rare subpopulations associated with advanced disease.

bioRxiv · Jan 25, 2021Cancer Biology

A distinct innate immune signature marks progression from mild to severe COVID-19

S. Chevrier, Y. Zurbuchen, C. Cervia, S. Adamo, M. E. Raeber, N. de Souza, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. J. Schaer, J. Nilsson, O. Boyman, B. Bodenmiller

The paper identifies an innate immune signature associated with progression from mild to severe COVID-19 using mass cytometry and proteomics.

bioRxiv · Aug 4, 2020Immunology

Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19

S. Adamo, S. Chevrier, C. Cervia, Y. Zurbuchen, M. E. Räber, L. Yang, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. Schaer, B. Bodenmiller, O. Boyman, J. Nilsson

This study identifies T cell apoptosis and migration as mechanisms of peripheral T cell lymphopenia in severe COVID-19 and links lymphopenia to subsequent T cell proliferation.

bioRxiv · Aug 4, 2020 · PreprintImmunology